Oracle Health Sciences

The way clinical trials are conducted in the European Union will undergo a major change when (EU) No 536/2014 comes into effect in January 2022. But just being compliant with the regulation should not be considered enough – forward-looking organizations are rethinking how technology can play an important part in bringing efficiencies to clinical trials, by reducing failures and driving operational changes beyond compliance.

***Live: Tuesday, October 26, 2021 at 11 EDT | 8am PDT | 5pm CEST | 4pm BST*** Oracle Health Sciences reveals new research conducted to understand the technology adaptations that were made to clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.

***Live: Tuesday, Oct. 20, 2020 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST*** Join Oracle Health Sciences and Michele Taylor-Scott, Head of Data Management at Health Decisions as they discuss why it is important for small to medium sized pharma and biotechs need to understand the technology landscape in order to work as educated partners with their CROs to help determine the most effective, fit-for-purpose solution for their clinical trials. Learn how a unified platform can help build a full study in a matter of weeks and reduce the overall time it takes to bring a drug to market. ***On demand available after final airing until Oct. 20, 2021***